Hypothalamic obesity due to acquired hypothalamic disorders is a significant cause of morbidity and excess mortality in affected patients. Available treatments are largely unsatisfactory as far as patients and physicians are concerned. Setmelanotide is approved by the US FDA for treatment of hypothalamic obesity due to genetic conditions. Recent reports show efficacy of this medication in patients with hypothalamic obesity due to acquired hypothalamic diseases. Dr. Lewis Blevins interviewed Dr.Susan Phillips, who presented the results of the clinical trial showing benefits and risks of treatment at The Endocrine Society Meeting in San Francisco, California in July 2025.
© 2025, J D Faccinetti. All rights reserved.
Hi I am Kalavathi R from bangalore India
From 2002 I have pituitary tumour
Underwent transphonidal surgery in 2002 and 2013 Gamma knife radiation
I am cabergoline 0.5mg 7 tab on Thursday and 7 tab on Monday and Hisone 10mg perday
Prolactin is under control
For Obesity is issue can I be prescribed setmelanotide
Please guide
Thank you for your note. You should consult your doctor. We do not give medical advice. Good luck and please stay connected.